Clonorchis sinensis Crude Antigen Suppresses Osteoclast Differentiation via Modulation of the NF‐κB and MAPK Signaling Pathway
Immunity, Inflammation and Disease · 2025
DOI: 10.1002/iid3.70292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2025. Verfasst von Lili Tang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Parasitology Department, School of Basic Medical Sciences, Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Clonorchis sinensis, Osteoclasts, Cell Differentiation, Antigens, Helminth. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by the Middle/Young aged Teachers' Research Ability Improvement Project of Guangxi Higher Education (Grant No. 2024KY0109) and Guangxi….
Abstract (Originalsprache)
Background
Clonorchis sinensis crude antigen ( Cs CA) is recognized for its immunomodulatory capacity in host‐pathogen interactions and immune‐related pathologies, its direct impact on bone remodeling cells remains underexplored. Although prior studies demonstrate Cs CA‐mediated suppression of inflammatory bone formation in ankylosing spondylitis, the specific regulatory effects on osteoclastogenesis and associated molecular mechanisms remain elusive. This study aimed to investigate the impact of Cs CA on osteoclast differentiation and its potential molecular mechanisms.
Methods
The cytotoxicity of Cs CA on mouse bone marrow–derived macrophages (BMMs) was evaluated using the CCK‐8 assay. At the established non‐cytotoxic dose, the effects of Cs CA on osteoclast morphology and activity were observed via TRAcP staining and F‐actin ring formation assay. Expression of osteoclast differentiation‐related genes and proteins was analyzed by combined RT‐qPCR and Western Blot. RNA‐seq was performed to identify Cs CA‐regulated signaling pathways during osteoclast differentiation, followed by validation of key pathway components through Western Blot and immunofluorescence.
Results
Cs CA exhibited no significant cytotoxicity on BMMs at concentrations ≤ 40 μg/mL. TRAcP staining revealed a significant reduction in osteoclast numbers in Cs CA‐treated groups. F‐actin ring formation assays demonstrated abnormal cytoskeletal structures. RT‐PCR results showed significantly downregulated expression of osteoclast differentiation‐related genes, including NFATc1 , c‐Fos , Acp5 , CTSK and MMP‐9 . Western Blot confirmed reduced protein expression levels of NFATc1 and c‐Fos. RNA‐seq analysis combined with experimental validation by Western Blot and immunofluorescence confirmed that Cs CA primarily inhibits osteoclast differentiation through the NF‐κB and MAPK signaling pathways.
Conclusions
Cs CA inhibits the formation and function of osteoclasts by suppressing the expression of key genes involved in osteoclast differentiation through the inhibition of the NF‐κB and MAPK signaling pathways. This study elucidates the mechanism by which Cs CA regulates osteoclasts and suggests its translational potential in preventing and treating hyper‐resorptive bone diseases such as osteoporosis and bone metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Parasitology Department, School of Basic Medical Sciences, Guangxi Medical University, Nanning, China.
- Guangxi Key Laboratory of Regenerative Medicine, Guangxi Medical University, Nanning, Guangxi, China.
- Education Department of Guangxi Zhuang Autonomous Region, Key Laboratory of Basic Research on Regional Diseases (Guangxi Medical University), Nanning, China.
- Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning, Guangxi, China.
- Histology and Embryology Department, School of Basic Medical Sciences, Guangxi Medical University, Nanning, China.
- Cell Biology and Genetics Department, School of Basic Medical Sciences, Guangxi Medical University, Nanning, China.
ORCID-Profile: Shanshan He, Tingzheng Zhan, Yunliang Shi
Förderung
- This study was supported by the Middle/Young aged Teachers' Research Ability Improvement Project of Guangxi Higher Education (Grant No. 2024KY0109) and Guangxi…
Zitieren
APA
Tang, L., He, S., Ma, B., Tang, Z., Zhan, T., Xiao, S., Wang, J., Zhao, J., Xu, J., & Shi, Y. (2025). Clonorchis sinensis Crude Antigen Suppresses Osteoclast Differentiation via Modulation of the NF‐κB and MAPK Signaling Pathway. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70292
Vancouver
Tang L, He S, Ma B, Tang Z, Zhan T, Xiao S, et al. Clonorchis sinensis Crude Antigen Suppresses Osteoclast Differentiation via Modulation of the NF‐κB and MAPK Signaling Pathway. Immunity, Inflammation and Disease. 2025. doi:10.1002/iid3.70292
BibTeX
@article{Tang2025,
author = {Tang, Lili and He, Shanshan and Ma, Buguo and Tang, Zeli and Zhan, Tingzheng and Xiao, Suyu and Wang, Jilong and Zhao, Jinmin and Xu, Jiake and Shi, Yunliang},
title = {Clonorchis sinensis Crude Antigen Suppresses Osteoclast Differentiation via Modulation of the NF‐κB and MAPK Signaling Pathway},
journal = {Immunity, Inflammation and Disease},
year = {2025},
doi = {10.1002/iid3.70292}
}
EUVIMED